BioCytics Inc
Brent Dixon is the Chief Technology Officer at BioCytics Inc and the Carolina BioOncology Institute. He also held the position of Director at the S.C. Department of Health & Environmental Control. With a Ph.D. in Analytical Chemistry and a background in Chemical Engineering and Clinical Management, Brent has a wealth of experience in laboratory operations and management. Additionally, he has worked in various roles such as Chief Scientist, Technical Director, and Adjunct Instructor in his career. Brent's expertise lies in areas such as clinical chemistry, toxicology, pharmacogenetics, and mass spectrometry.
This person is not in any teams
BioCytics Inc
BioCytics via the Human Applications Lab is focused on bringing personalized oncology treatments to the market. BioCytics has an ongoing IRB-approved clinical trial (BioCytics 0001; NCT00571389) that allows for the collection and study of blood and tissue samples from consenting cancer patients. We are incubated within Carolina BioOncology - a preferred cancer treatment and Phase I drug testing facility. BioCytics was founded by Dr. John Powderly, MD, medical board certified oncologist and a certified physician investigator (CPI), who is also president of Carolina BioOncology Institute (CBOI).